News

Study 11565 administered 183 patients with one of five different dose regimens of SAR236553/REGN727, either 50mg, 100mg, or 150mg Q2W, or 200mg or 300mg Q4W alternating with placebo

The new site includes 800m² for discovery and process development through new laboratory, piloting and FAT testing areas. By increasing the engineering capabilities, Novasep will expand output for

Impax Laboratories president and CEO Larry Hsu said in the past two years, the company has entered into four distinct partnerships for alternative dosage form products. "Our business

Under the agreement, Hanmi will be in charge of formulation research, early clinical studies and manufacturing, and GSK will be in charge of late stage clinical studies and

The transaction, which is subject to regulatory approval and other customary closing conditions, including the approval of ISTA’s shareholders, is expected to close in the second quarter of

QNASL is delivered as a once-daily, pressurized, HFA-propelled nonaqueous aerosol that is environmentally friendly and offers a built-in dose counter. The company plans to market the nonaqueous or

The Korlym has received FDA approval for patients with endogenous Cushing’s syndrome. PharmaForm is a full-service contract provider of development and manufacturing for the pharmaceutical and biotech industry.

Subsys is a sublingual spray formulation of free fentanyl in a single unit-dose delivery device which disperses a fine mist over a broad sublingual area. The fentanyl sublingual

The two year, $600,000 grant will be used to identify novel highly protective antigens for malaria vaccine development. The work under this grant will build on the research